Followers | 228 |
Posts | 14889 |
Boards Moderated | 1 |
Alias Born | 03/29/2014 |
Wednesday, December 29, 2021 11:16:25 AM
The three pharmas were responding to requests from FDA on their “Benefit Risk” guidance put out in September 2021:
https://www.fda.gov/media/152544/download
…and Lykiri’s letter to FDA concerned the “Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products” guidance from December 2019 found here (and liked above in the board information - I’ll add the link to the previous Benefit-Risk guidance in the section above later today):
https://www.fda.gov/media/133660/download
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM